Medically reviewed by Christopher Koller, M.D., director of urologic oncology at Hackensack Meridian Clifton Health and Wellness Center at Clifton Prostate cancer is the most common cancer in men across the United States — and it’s on the rise, particularly in New…
Record US Quarter: How Is Cyclopharm (ASX:CYC) Building on It? New Leaders, Big Test: Where Is IPH (ASX:IPH) Heading at Its AGM? The milestone is significant for a clinical-stage company whose valuation rests heavily on the success of…
Dictionary · 11 pages 1,858 shared terms across 29 research-administration domains, open under CC-BY 4.0. CRediT · 11 pages 14 contributor roles, standardised as ANSI/NISO Z39.104-2022 and adopted by thousands of journals. NIKOLAI · 14 pages NIKOLAI — Nomenclature & Index for Knowledge Ontologies, Lexicons & AI Interoperability CASRAI's frontier-AI-safety dictionary — 64 elements crosswalked…
The approval is supported by Phase 3 INSPIRE-1 and INSPIRE-2 clinical studies, which evaluated the efficacy and safety of ILUMYA after only two doses at 24 weeks in adult patients with active psoriatic arthritis. About the INSPIRE-1 and INSPIRE-2 Phase 3 StudiesINSPIRE-1 and…
Annually, three candidates are selected for the five-year program. Our residents benefit from a formal surgical skills curriculum consisting of monthly sessions in open, laparoscopic, robotic, microscopic, and endoscopic skills. Robotic and laparoscopic training includes simulators as well as dry-lab…
Fellowship Director Professor of Urology Associate Professor of Urology Professor of Obstetrics and Gynecology Clinical Professor of Surgery (General Surgery) Clinical Assistant Professor of Urology We will not be participating in the 2027 Match cycle, as all available positions are filled.
Dr. Nastiuk initiated the current study to better understand how hormonal anti-androgen therapy (ADT) reshapes the immune landscape around prostate cancers. What is already known on this topic What this study adds This investigation was supported by the National Cancer…
- Aamir Malik, Executive Vice President, Chief U.S. Commercial Officer, Pfizer - Neeraj Agarwal, M.D., FASCO, Co-director of Prostate Cancer Program at Harvard Cancer Consortium, faculty medical oncologist at Dana-Farber Cancer Institute, and global lead investigator for TALAPRO-3 TALZENNA plus XTANDI was first approved…
Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. Individuals' genetic background may affect ceramide metabolism to influence whether they benefit from androgen receptor…
Newswise — In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity and pain for patients with metastatic prostate cancer. “This is a first-in-class drug for prostate cancer,” says Daniel Petrylak,…
BPH, prostatitis, PSA screening, and urinary/sexual function concerns.
An article joins this feed when it matches these terms. Each one is also a search of its own.